berotek and iloprost
berotek has been researched along with iloprost in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Farmer, P; Pugin, J | 1 |
Other Studies
2 other study(ies) available for berotek and iloprost
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
beta-adrenergic agonists exert their "anti-inflammatory" effects in monocytic cells through the IkappaB/NF-kappaB pathway.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Anti-Inflammatory Agents, Non-Steroidal; Bucladesine; Cell Line; Cell Nucleus; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dinoprostone; DNA-Binding Proteins; Enzyme Activation; Epinephrine; Fenoterol; Gene Expression Regulation; Humans; I-kappa B Proteins; Iloprost; Interleukin-8; Isoproterenol; Kinetics; Lipopolysaccharide Receptors; Lipopolysaccharides; Monocytes; NF-kappa B; NF-KappaB Inhibitor alpha; Norepinephrine; Tumor Necrosis Factor-alpha | 2000 |